{"id":"https://openalex.org/W2062860024","doi":"https://doi.org/10.2165/00002018-199308010-00008","title":"An International Comparison of Case Definition of Severe Adverse Cutaneous Reactions to Medicines","display_name":"An International Comparison of Case Definition of Severe Adverse Cutaneous Reactions to Medicines","publication_year":1993,"publication_date":"1993-01-01","ids":{"openalex":"https://openalex.org/W2062860024","doi":"https://doi.org/10.2165/00002018-199308010-00008","mag":"2062860024","pmid":"https://pubmed.ncbi.nlm.nih.gov/8338525"},"language":"en","primary_location":{"id":"doi:10.2165/00002018-199308010-00008","doi":"https://doi.org/10.2165/00002018-199308010-00008","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00002018-199308010-00008","pdf_url":null,"source":{"id":"https://openalex.org/S49488433","display_name":"Drug Safety","issn_l":"0114-5916","issn":["0114-5916","1179-1942"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Safety","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103694507","display_name":"Robert S. Stern","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert S. Stern","raw_affiliation_strings":["Department of Dermatology, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts","Beth Israel Hospital, Harvard Medical School"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Beth Israel Hospital, Harvard Medical School","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067760142","display_name":"Edith Albengres","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edith Albengres","raw_affiliation_strings":["Centre de Pharmacovigilance de Cr\u00e9teil, Centre Hospital, Cr\u00e9teil, France","Centre Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre de Pharmacovigilance de Cr\u00e9teil, Centre Hospital, Cr\u00e9teil, France","institution_ids":[]},{"raw_affiliation_string":"Centre Hospital","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Johan Carlson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Johan Carlson","raw_affiliation_strings":["F. Hoffmann La Roche Limited, Basel, Switzerland","F. Hoffmann-La Roche Limited"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann La Roche Limited, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"F. Hoffmann-La Roche Limited","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051642696","display_name":"Diane Chen","orcid":"https://orcid.org/0000-0002-7302-9248","observed_orcids":["https://orcid.org/0000-0002-7302-9248"]},"institutions":[{"id":"https://openalex.org/I1319126558","display_name":"Medical Products Agency","ror":"https://ror.org/0356c4a29","country_code":"SE","type":"government","lineage":["https://openalex.org/I1319126558"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Diane Chen","raw_affiliation_strings":["Section of Pharmacoepidemiology, Medical Products Agency, Uppsala, Sweden","Medical Products Agency"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Pharmacoepidemiology, Medical Products Agency, Uppsala, Sweden","institution_ids":["https://openalex.org/I1319126558"]},{"raw_affiliation_string":"Medical Products Agency","institution_ids":["https://openalex.org/I1319126558"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051829622","display_name":"Carmen Kraft","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carmen Kraft","raw_affiliation_strings":["Centre de Pharmacovigilance de Cr\u00e9teil, Centre Hospital, Cr\u00e9teil, France","Centre Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre de Pharmacovigilance de Cr\u00e9teil, Centre Hospital, Cr\u00e9teil, France","institution_ids":[]},{"raw_affiliation_string":"Centre Hospital","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103540067","display_name":"Wanju S. Dai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Wanju Dai","raw_affiliation_strings":["F. Hoffmann La Roche Incorporated, Nutley, New Jersey, USA","F. Hoffmann-La Roche Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann La Roche Incorporated, Nutley, New Jersey, USA","institution_ids":[]},{"raw_affiliation_string":"F. Hoffmann-La Roche Inc","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael Joseph","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Joseph","raw_affiliation_strings":["Burroughs Wellcome Company, Research Triangle Park, North Carolina, USA","Burroughs Wellcome Company"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Burroughs Wellcome Company, Research Triangle Park, North Carolina, USA","institution_ids":[]},{"raw_affiliation_string":"Burroughs Wellcome Company","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109177580","display_name":"Hugh A. Tilson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hugh Tilson","raw_affiliation_strings":["Burroughs Wellcome Company, Research Triangle Park, North Carolina, USA","Burroughs Wellcome Company"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Burroughs Wellcome Company, Research Triangle Park, North Carolina, USA","institution_ids":[]},{"raw_affiliation_string":"Burroughs Wellcome Company","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110266205","display_name":"Bengt\u2010Erik Wiholm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Bengt-Erik Wiholm","raw_affiliation_strings":["F. Hoffmann La Roche Limited, Basel, Switzerland","F. Hoffmann-La Roche Limited"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann La Roche Limited, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"F. Hoffmann-La Roche Limited","institution_ids":["https://openalex.org/I118019719"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":null,"fwci":0.3124,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.57769181,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"8","issue":"1","first_page":"69","last_page":"77"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.01940000057220459,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/toxic-epidermal-necrolysis","display_name":"toxic epidermal necrolysis","score":0.9919999837875366},{"id":"https://openalex.org/keywords/stevens-johnson-syndrome","display_name":"Stevens-Johnson syndrome","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.75},{"id":"https://openalex.org/keywords/case-definition","display_name":"case definition","score":0.7670000195503235},{"id":"https://openalex.org/keywords/intercountry-variation","display_name":"intercountry variation","score":0.7269999980926514},{"id":"https://openalex.org/keywords/diagnostic-agreement","display_name":"diagnostic agreement","score":0.6790000200271606},{"id":"https://openalex.org/keywords/spontaneous-adverse-event-reporting","display_name":"spontaneous adverse event reporting","score":0.5049999952316284},{"id":"https://openalex.org/keywords/cross-national-comparison","display_name":"cross-national comparison","score":0.5109999775886536}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9125093817710876},{"id":"https://openalex.org/C534262118","wikidata":"https://www.wikidata.org/wiki/Q177719","display_name":"Medical diagnosis","level":2,"score":0.7536237239837646},{"id":"https://openalex.org/C2780664588","wikidata":"https://www.wikidata.org/wiki/Q1878682","display_name":"Toxic epidermal necrolysis","level":2,"score":0.6409875154495239},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.5945425033569336},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.37006908655166626},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.29264843463897705},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.21216699481010437},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.11681193113327026},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.11284291744232178}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004892","descriptor_name":"Erythema Multiforme","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004892","descriptor_name":"Erythema Multiforme","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007391","descriptor_name":"International Cooperation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013262","descriptor_name":"Stevens-Johnson Syndrome","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D013262","descriptor_name":"Stevens-Johnson Syndrome","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D013262","descriptor_name":"Stevens-Johnson Syndrome","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2165/00002018-199308010-00008","doi":"https://doi.org/10.2165/00002018-199308010-00008","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00002018-199308010-00008","pdf_url":null,"source":{"id":"https://openalex.org/S49488433","display_name":"Drug Safety","issn_l":"0114-5916","issn":["0114-5916","1179-1942"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Safety","raw_type":"journal-article"},{"id":"pmid:8338525","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8338525","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug safety","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1988845822","https://openalex.org/W2038163817","https://openalex.org/W2040099759","https://openalex.org/W2067561788","https://openalex.org/W2164777277","https://openalex.org/W4237406238","https://openalex.org/W4247701171","https://openalex.org/W4250260862","https://openalex.org/W4253517485"],"related_works":["https://openalex.org/W2000444091","https://openalex.org/W4400782169","https://openalex.org/W2221798782","https://openalex.org/W3201321620","https://openalex.org/W4402581515","https://openalex.org/W1972655666","https://openalex.org/W4254876722","https://openalex.org/W2894921576","https://openalex.org/W2111379158","https://openalex.org/W7223459153"],"abstract_inverted_index":null,"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}